Profitelligence Profitelligence · Filing Ledger Open CI research →

Form 8-K · Current Report · Filed 2024-08-01

The Cigna Group Reports Strong Second Quarter 2024 Results

The Cigna Group reported strong financial results for the second quarter of 2024, with total revenues increasing by 25% to $60.5 billion, driven by significant growth in Evernorth Health Services.

Filer
The Cigna Group CI · NYSE
Filed
Accession
0000950159-24-000233
CIK
0001739940
Signal
High impactHealthcare

Details

Shareholders' net income increased to $1.5 billion, or $5.45 per share, and adjusted income from operations rose 5% to $1.9 billion, or $6.72 per share. The company also provided a full-year 2024 outlook with adjusted revenues expected to be at least $235.0 billion and adjusted income from operations at least $8.065 billion. Additional financial details and reconciliations are provided in the furnished exhibit.

Items reported

Item 2.02

Results of Operations and Financial Condition

Earnings Beat Raised Guidance
Item 9.01

Financial Statements and Exhibits

Exhibits Furnished

Market reaction

Close before filing

$348.67

Next session

-3.3%

Since filing

-20.0%

Latest close

$279.05

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from CI reporting the same item, with the next session's move:

Exhibits (1)

About The Cigna Group

The Cigna Group is a leading global health services organization. Ranging across a comprehensive spectrum of health and wellness services, the company aims to improve the health, well-being, and peace of mind of those it serves. Notably, Cigna offers medical, dental, disability, life, and accident insurance coverage to individuals and businesses, extending its reach from individual clients to multinational corporations. Its primary business comprehends a vast network within the managed care sector, focusing on providing accessible and affordable healthcare solutions to its users. Cigna’s influence spans multiple sectors including health insurance, pharmacy benefit management, and behavioral health, highlighting its diverse portfolio. The company plays a crucial role in the health insurance market, consistently driving innovation in healthcare solutions and cost management. Its ability to integrate health services and provide holistic care solutions is pivotal in addressing the evolving needs of the healthcare landscape globally."}

Exchange NYSE Industry Healthcare Plans Company website ↗

Never miss another CI filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts